Market Place
Sourcing Support
All News #Library
Others
Atsena Therapeutics Names Mcdavid Stilwell CFO
06 Jan 2026 //
GLOBENEWSWIRE
Atsena Therapeutics, FDA Align on ATSN-201 Approval Path for XLRS
09 Jul 2025 //
GLOBENEWSWIRE
Atsena Therapeutics Receives FDA RMAT Designation for ATSN-101
14 Nov 2023 //
GLOBENEWSWIRE
Atsena downsizes to funnel money toward new capsid program
05 Oct 2023 //
FIERCE BIOTECH
Atsena Therapeutics Receives FDA Clearance of IND Application for ATSN-201
01 May 2023 //
GLOBENEWSWIRE
Atsena Therapeutics Announces Positive 6-month from Ongoing Ph I/II Clinical
25 Apr 2023 //
GLOBENEWSWIRE
Atsena to Present at NewYorkBIO’s December 2022 Emerging Life Science
07 Dec 2022 //
GLOBENEWSWIRE
Atsena Therapeutics Announces Positive Results from Phase I/II Clinical Trial
03 Oct 2022 //
GLOBENEWSWIRE
Atsena Therapeutics Announces Late-Breaker Presentation at Ophthalmology 2022
21 Sep 2022 //
GLOBENEWSWIRE
Atsena Therapeutics Announces Opening of New Office and Laboratory Space
27 Jul 2022 //
GLOBENEWSWIRE
Atsena Therapeutics Announces Presentations at ARVO and ASGCT
02 May 2022 //
GLOBENEWSWIRE
Atsena Therapeutics Unveils XLRS Gene Therapy Program Leveraging Novel Capsids
18 Oct 2021 //
GLOBENEWSWIRE
Atsena Therapeutics Appoints Linda B. Couto, PhD, as Chief Scientific Officer
16 Aug 2021 //
GLOBENEWSWIRE
Atsena Therapeutics Appoints Jennifer Wellman to Board of Directors
12 Jul 2021 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.